Scarring Alopecia

Inflammation can damage the follicular stem-cell region, which is essential for maintaining the follicle’s ability to produce hair. Once this area is destroyed, the follicle is replaced by scar tissue rather than recovering normal growth. This mechanism explains why prompt clinical recognition matters: treatment may preserve follicles that remain viable but cannot restore those already permanently damaged.

Several types of injury may initiate the follicular damage, including immune-mediated attack, infection, trauma, or other forms of tissue injury. These triggers do not necessarily produce identical clinical patterns, so determining the likely cause is important when evaluating a patient. Identifying the cause helps clinicians distinguish possible disease processes and select condition-specific treatment.

Redness, scaling, pustules, pain, and itching are important warning findings, particularly when they occur with hair loss. These features suggest an active scalp process that may be damaging follicles. Their presence should prompt medical assessment rather than reliance on hair-growth observation alone, because ongoing inflammation may reduce the number of follicles that can be preserved.

The distinction requires more than observing reduced hair density. Clinicians combine the patient’s history with direct scalp examination and dermoscopy, an examination method that provides a closer view of scalp and follicular features. When the diagnosis or cause remains uncertain, a biopsy may be performed to evaluate tissue changes and help separate permanent follicular damage from other forms of alopecia.

Treatment primarily aims to suppress inflammation and preserve the remaining follicles. Because destroyed follicles cannot be expected to recover normal growth, management focuses on limiting continuing injury rather than promising complete regrowth. The specific medication approach depends on the underlying condition, making diagnostic evaluation important before selecting therapy and monitoring whether disease activity is controlled.

Surgical restoration may be considered only after the disease activity has been controlled. Proceeding while inflammation remains active could be inappropriate because the underlying process may still threaten follicles and affect the result. Therefore, clinicians first focus on controlling the condition and preserving viable hair. Restoration is a later option for selected patients, not the initial response to active disease.